Tokushima, Japan

Yoshihisa Takaishi

This inventor holds 2 USPTO granted patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Otsuka Pharmaceutical Factory, Inc.. Active years: 1993-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihisa Takaishi. Retrieved from https://idiyas.com/inventor/yoshihisa-takaishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1993-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Yoshihisa Takaishi

Introduction

Yoshihisa Takaishi is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of nitric oxide-associated diseases. With a total of 2 patents, Takaishi's work has garnered attention in the scientific community.

Latest Patents

Takaishi's latest patents include a "Method of treating a nitric oxide-associated disease with phenanthrene" and "Phenanthrene derivatives." These innovations reflect his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout his career, Takaishi has worked with prominent companies such as Otsuka Pharmaceutical Company, Limited and Otsuka Pharmaceutical Factory, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Takaishi has collaborated with esteemed colleagues, including Yukihisa Ono and Yoshihiro Taniguchi. These partnerships have contributed to the success of his projects and the advancement of his research.

Conclusion

Yoshihisa Takaishi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of diseases and showcases the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…